Navigation Links
Combination of imaging exams improves Alzheimer's diagnosis
Date:12/10/2012

OAK BROOK, Ill. A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease, according to a new study published online in the journal Radiology.

"Because new treatments are likely to be most effective at the earliest stages of Alzheimer's disease, there is great urgency to develop sensitive markers that facilitate detection and monitoring of early brain changes in individuals at risk," said Jeffrey R. Petrella, M.D., associate professor of radiology, division of neuroradiology, and director of the Alzheimer's Disease Research Lab at Duke University Medical Center (DUMC) in Durham, N.C. "Our study looks at whether more sophisticated diagnostic tests such as magnetic resonance imaging (MRI), positron emission tomography (PET) and spinal fluid protein analysis might provide additional prognostic information, compared to more readily available cognitive and blood testing."

According to the World Health Organization, more than 35 million people worldwide are living with Alzheimer's disease, which is incurable, and the prevalence is expected to double by 2030.

"Although there is no cure for Alzheimer's disease, there are four symptomatic treatments that might provide some benefits," said coauthor P. Murali Doraiswamy, M.D., professor of psychiatry at DUMC. "So developing the right combination of diagnostic tests is critical to make sure we enable an accurate and early diagnosis in patients, so they can evaluate their care options."

The Duke study looked at 97 patients with MCI from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a national multicenter biomarker study in which patients are followed serially to track disease progression. The researchers analyzed baseline MRI and FDG-PET results, as well as cerebrospinal fluid proteins and compared these to cognitive outcomes at two to three years.

The findings showed that combining MRI, FDG-PET and cerebrospinal fluid data with routine clinical tests significantly increased the accuracy of predicting conversion to Alzheimer's disease over clinical testing alone. In addition, the combined testing reduced false classifications. The misclassification rate decreased from 41.3 percent to 28.4 percent.

The researchers also analyzed the individual contributions of the various exams.

"In an ideal world, you'd obtain all information availableregardless of cost or number of testsfor the best prediction of cognitive decline," Dr. Petrella said. "However, there's a trade-off between adding testingsome of which may add little new informationwith the inconvenience, cost and risk to the patient."

Among the exams, FDG-PET contributed more information to routine tests than did cerebrospinal fluid or MRI.

"Though all the tests added some unique information," Dr. Petrella said, "FDG-PET appeared to strike the best balance, adding the most prognostic information for patients with mild cognitive impairment."

The researchers caution that additional long-term studies are needed to further validate the data.

ADNI was launched in 2003 and is a national, multi-site study of elderly patients with and without Alzheimer's disease and MCI. ADNI is the result of efforts of many co-investigators from academic institutions and private corporations. Patients were recruited from over 50 sites across the U.S. and Canada.


'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Drug combination acts against aggressive chronic lymphocytic leukemia
2. Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
3. Combination treatment may improve survival of breast cancer patients with brain metastases
4. Drug combination against NRAS-mutant melanoma discovered
5. Combination peptide therapies might offer more effective, less toxic cancer treatment
6. DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination
7. BUSM in vitro study identifies potential combination therapy for breast cancer
8. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
9. Discovery suggests new combination therapy strategy for basal-like breast cancers
10. Cancer vaccine combination therapy shows survival benefit in breast cancer
11. Combination of 2 drugs reverses liver tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... ... web-based software module. The cutting-edge feature provides end users with an embedded, ... self-service business intelligence solution and its analytics engine. , This powerful ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... alkaline water, a revolutionary new beverage for pregnant women to prevent morning sickness ... vitamins and alkaline minerals with the look and taste of water. , “Imagine ...
(Date:5/23/2016)... ... May 23, 2016 , ... Edward D. Buckingham, M.D . is ... Physicians. The annual roster is put out by the National Consumer Advisory Board to ... outstanding care are considered for this award. , The National Consumer Advisory Board (NCAB) ...
(Date:5/23/2016)... , ... May 23, 2016 , ... According to an ... in an exuberant mood since the birth of her son, Rockwell Lloyd Liu, and ... ever had.” The “Elementary” and “Kill Bill” star explains that, as a career oriented ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... objectification, according to Georgia State University researchers. , In a recent ... fifth, sixth and seventh grades shared their experiences with strained relationships, recurring ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Dutch surgeons have launched a ground-breaking medical app to ... patients on a global scale. Medical professionals from Europe ... and the US have already signed up for the app, ... totally secure environment. Education  "Imagine a doctor ... a surgeon at Harvard to treat a bomb victim via live ...
(Date:5/24/2016)... 2016 Een app die artsen ... collectief patiënten kunnen behandelen, hun kennis kunnen delen en ... de nieuwe en revolutionaire MDLinking App, ontwikkeld door een ... dr. Hans Flu en oncologisch chirurg dr. Gijs ... is, wordt op dinsdag 24 mei officieel gepresenteerd op ...
(Date:5/23/2016)... 23, 2016 According to ... Market by Product (Wheelchair, Scooters, Medical Beds, Bathroom ... Critical Care, Wound), Accessories (Lifting, Transfer) & by ... published by MarketsandMarkets, the patient handling equipment market ... 2021 at a CAGR of 10.5% during the ...
Breaking Medicine Technology: